https://www.selleckchem.com/products/jsh-23.html
01 to -0.60, P0.0001) and transfused red blood cell volume (SMD 0.92, 95% CI -1.30 to -0.53, P0.0001). Two studies reported that complication rates were comparable between patients receiving IABO and patient receiving conventional surgery (Odds ratio=1.29, 95% CI 0.59 to 2.83, P=0.52). All studies descriptively reported improved visualization of the operative field with IABO. Our findings demonstrated that IABO is an effective technique to decrease blood loss and transfusion requirements during sacral and pelvic tumor surgery. Fu